Drugs / Sublingual allergy immunological tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04176185 | Nov → Dec 2019 | allergic disease | ALK-Abelló A/S | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sublingual allergy immunological tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04176185 ↗ |